Cargando…
Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867110/ https://www.ncbi.nlm.nih.gov/pubmed/35216675 http://dx.doi.org/10.1016/j.ccell.2022.02.011 |
| _version_ | 1784655983073558528 |
|---|---|
| author | Ehmsen, Sidse Asmussen, Anders Jeppesen, Stefan S. Nilsson, Anna Christine Østerlev, Sabina Kragh, Amalie Frederiksen, Henrik Ditzel, Henrik J. |
| author_facet | Ehmsen, Sidse Asmussen, Anders Jeppesen, Stefan S. Nilsson, Anna Christine Østerlev, Sabina Kragh, Amalie Frederiksen, Henrik Ditzel, Henrik J. |
| author_sort | Ehmsen, Sidse |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8867110 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88671102022-02-24 Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination Ehmsen, Sidse Asmussen, Anders Jeppesen, Stefan S. Nilsson, Anna Christine Østerlev, Sabina Kragh, Amalie Frederiksen, Henrik Ditzel, Henrik J. Cancer Cell Letter Elsevier Inc. 2022-04-11 2022-02-24 /pmc/articles/PMC8867110/ /pubmed/35216675 http://dx.doi.org/10.1016/j.ccell.2022.02.011 Text en © 2022 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter Ehmsen, Sidse Asmussen, Anders Jeppesen, Stefan S. Nilsson, Anna Christine Østerlev, Sabina Kragh, Amalie Frederiksen, Henrik Ditzel, Henrik J. Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination |
| title | Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination |
| title_full | Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination |
| title_fullStr | Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination |
| title_full_unstemmed | Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination |
| title_short | Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination |
| title_sort | antibody responses following third mrna covid-19 vaccination in patients with cancer and potential timing of a fourth vaccination |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867110/ https://www.ncbi.nlm.nih.gov/pubmed/35216675 http://dx.doi.org/10.1016/j.ccell.2022.02.011 |
| work_keys_str_mv | AT ehmsensidse antibodyresponsesfollowingthirdmrnacovid19vaccinationinpatientswithcancerandpotentialtimingofafourthvaccination AT asmussenanders antibodyresponsesfollowingthirdmrnacovid19vaccinationinpatientswithcancerandpotentialtimingofafourthvaccination AT jeppesenstefans antibodyresponsesfollowingthirdmrnacovid19vaccinationinpatientswithcancerandpotentialtimingofafourthvaccination AT nilssonannachristine antibodyresponsesfollowingthirdmrnacovid19vaccinationinpatientswithcancerandpotentialtimingofafourthvaccination AT østerlevsabina antibodyresponsesfollowingthirdmrnacovid19vaccinationinpatientswithcancerandpotentialtimingofafourthvaccination AT kraghamalie antibodyresponsesfollowingthirdmrnacovid19vaccinationinpatientswithcancerandpotentialtimingofafourthvaccination AT frederiksenhenrik antibodyresponsesfollowingthirdmrnacovid19vaccinationinpatientswithcancerandpotentialtimingofafourthvaccination AT ditzelhenrikj antibodyresponsesfollowingthirdmrnacovid19vaccinationinpatientswithcancerandpotentialtimingofafourthvaccination |